MetaCap

Cellyan Biotechnology Co. Ltd Class A (HKPD)

NASDAQ: HKPDHealth CareOther PharmaceuticalsUSD

1.38+0.035 (+2.60%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HKPD stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$1.38
52-week range
1.20 – 22.10
Day range
1.29 – 1.41
Volume / Avg
93.94K / 183.65K
Beta
—

52-week range

$1.20$22.10

HKPD stock today

Cellyan Biotechnology (HKPD) closed at $1.38 on Nov 20, up 2.60% (+$0.035), versus the S&P 500's 3.70% decline. Shares are 93.8% below their 52-week high of $22.10 and 15.0% above the 52-week low of $1.20, near the bottom of the past year's range. Cellyan Biotechnology has posted a net loss over the last twelve months (EPS of -$1.38), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Cellyan Biotechnology

Company profile

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services.

Industry
Other Pharmaceuticals
CEO
Mr. Chenyu Liang
Headquarters
Yau Tong
Employees
11
IPO year
2025
Website
9zt.hk

Financial highlights

Full financials

In fiscal 2025, Cellyan Biotechnology generated $20.3 million in revenue, up 21.7% from fiscal 2024, its 2nd consecutive year of revenue growth. Cellyan Biotechnology reported a net loss of $27,056, compared with net income of $1.3 million a year earlier. Gross margin was 11.9% (down from 21.3%) and operating margin -11.2%.

Cellyan Biotechnology annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023
Revenue$20.31M$16.69M$12.56M
Growth+21.72%+32.91%—
Net income$-27.06K$1.33M$998.20K
EPS (diluted)$-0.003$0.18$0.146

HKPD news

All HKPD news

Cellyan Biotechnology peers

Health Care sector
HKPD peer companies
CompanyPrice% ChgMarket capCompare
MEDSDataMeds AI Inc.1.34+84.14%$7.67Mvs HKPD
COSMCosmos Health Inc.2.81-2.09%$14.14Mvs HKPD
ESYNEnerSyn Global Inc.1.11-0.89%$37.44Mvs HKPD
NUSNu Skin Enterprises Inc.3.80+0.80%$184.98Mvs HKPD
HLFHerbalife Ltd.15.53-0.26%$1.63Bvs HKPD
CAHCardinal Health Inc.272.81+0.17%$63.06Bvs HKPD
CORCencora Inc.339.09-0.63%$64.71Bvs HKPD
MCKMcKesson Corporation1,069.43+0.68%$123.47Bvs HKPD

Indexes, lists and sector

Cellyan Biotechnology stock FAQ

What is Cellyan Biotechnology's stock price today?

HKPD last traded at $1.38 as of Nov 20, 4:00 PM EST, up 2.60% on the day. Prices are delayed at least 15 minutes.

Does Cellyan Biotechnology pay a dividend?

No. Cellyan Biotechnology does not currently pay a regular cash dividend.

Who is Cellyan Biotechnology's CEO?

Mr. Chenyu Liang is the chief executive officer of Cellyan Biotechnology Co. Ltd Class A, which has about 11 employees.

Has HKPD ever split its stock?

Yes. The most recent HKPD stock split was a 1-for-20 split on Oct 26, 2026.

What is the HKPD 52-week high?

The 52-week high for HKPD is $22.10 and the 52-week low is $1.20. The stock is currently 93.8% below its high.

Compare HKPD